Jamjoom Pharmaceuticals Factory Company (TADAWUL:4015)
Saudi Arabia
· Delayed Price · Currency is SAR 137.50
+2.50 (1.85%)
At close: Mar 9, 2026
TADAWUL:4015 Revenue
Jamjoom Pharmaceuticals Factory Company had revenue of 342.31M SAR in the quarter ending September 30, 2025, with 4.50% growth. This brings the company's revenue in the last twelve months to 1.46B, up 14.83% year-over-year. In the year 2024, Jamjoom Pharmaceuticals Factory Company had annual revenue of 1.32B with 19.77% growth.
Revenue (ttm)
1.46B
Revenue Growth
+14.83%
P/S Ratio
6.60
Revenue / Employee
n/a
Employees
1,255
Market Cap
9.61B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Sulaiman Al Habib Medical Services Group Company | 13.71B |
| Nahdi Medical Company | 9.99B |
| Mouwasat Medical Services Company | 3.09B |
| Dallah Healthcare Company | 3.77B |
| Dr. Soliman Abdel Kader Fakeeh Hospital Company | 3.03B |
| Almoosa Health Company | 1.36B |
| National Medical Care Company | 1.60B |
| Specialized Medical Company | 1.46B |